Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People With HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study
Tristan Lee, Matthias Cavassini, Annalisa Marinosci, David Haerry et autres
Background: Integrase strand transfer inhibitors (INSTIs) are highly effective components of antiretroviral therapy for HIV. Recent studies suggest increased cardiovascular disease (CVD) risk after INSTI initiation, but findings remain inconsistent. The Swiss HIV Cohort Study is nationally representative, collects high-quality data, and …
ch, us (code pays fourni par la source)
0 citations
Open Forum Infectious Diseases